{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Plattsburgh",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89059",
      "recalling_firm": "SterRx, LLC",
      "address_1": "141 Idaho Ave",
      "address_2": "",
      "postal_code": "12903-3987",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "U.S.A. Nationwide",
      "recall_number": "D-0319-2022",
      "product_description": "NOREPINEPHRINE, 16 mg per 250 mL, (64 mcg per mL) in 5% Dextrose Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-002-01.",
      "product_quantity": "1044 bags",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20211112",
      "center_classification_date": "20211229",
      "termination_date": "20231206",
      "report_date": "20220105",
      "code_info": "S21194/CDW",
      "more_code_info": ""
    }
  ]
}